James Karrels - 07 Feb 2025 Form 4 Insider Report for MACROGENICS INC (MGNX)

Signature
Beth A. Smith, Attorney-in-fact
Issuer symbol
MGNX
Transactions as of
07 Feb 2025
Net transactions value
-$10,039
Form type
4
Filing time
11 Feb 2025, 20:30:26 UTC
Previous filing
06 Mar 2024
Next filing
19 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise +10,002 +5.8% 181,454 08 Feb 2025 Direct F1, F2
transaction MGNX Common Stock Tax liability $10,039 -3,861 -2.1% $2.60 177,593 08 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Employee Stock Option (right to buy) Award $0 +113,000 $0.000000 113,000 07 Feb 2025 Common Stock 113,000 $2.60 Direct F3
transaction MGNX Restricted Stock Unit Award $0 +19,000 $0.000000 19,000 07 Feb 2025 Common Stock 19,000 Direct F4
transaction MGNX Restricted Stock Unit Options Exercise $0 -10,002 -33% $0.000000 19,998 08 Feb 2025 Common Stock 10,002 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 8, 2024 the reporting person was granted 30,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
F2 Owned jointly with reporting person's wife.
F3 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
F4 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.